JIMT-1Homo sapiens (Human)Cancer cell line

Also known as: JIMT, JIMT1

🤖 AI SummaryBased on 10 publications

Quick Overview

Human breast cancer cell line with ErbB2 overexpression

Detailed Summary

JIMT-1 is a human breast cancer cell line derived from a pleural effusion of a patient with metastatic breast cancer. It is characterized by overexpression of the ErbB2 (HER2) receptor, making it a valuable model for studying HER2-positive breast cancers. The cell line is commonly used in research to investigate the molecular mechanisms of HER2-driven tumorigenesis and to test targeted therapies against HER2. JIMT-1 has been utilized in studies involving gene expression profiling, drug sensitivity assays, and the identification of potential therapeutic targets. Its genetic and molecular profile provides insights into the biology of HER2-positive breast cancers and contributes to the development of personalized treatment strategies.

Research Applications

HER2-positive breast cancer researchTargeted therapy developmentGene expression profilingDrug sensitivity assays

Key Characteristics

ErbB2 overexpressionMetastatic originSuitable for in vitro studies
Generated on 6/18/2025

Basic Information

Database IDCVCL_2077
SpeciesHomo sapiens (Human)
Tissue SourcePleural effusion[UBERON:UBERON_0000175]

Donor Information

Age62
Age CategoryAdult
SexFemale
Subtype Featuresbasal_A HER2+

Disease Information

DiseaseBreast ductal carcinoma
LineageBreast
SubtypeBreast Invasive Ductal Carcinoma
OncoTree CodeIDC

DepMap Information

Source TypeDSMZ
Source IDACH-000711_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg248Trp (c.742C>T)HomozygousSomatic mutation acquired during proliferationfrom parent cell line VCaP
MutationSimplePIK3CAp.Cys420Arg (c.1258T>C)Heterozygous-from parent cell line JIMT-1

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12,13
D10S1248
16
D12S391
17
D13S317
8,13
D16S539
11
D18S51
10
D19S433
12,13
D1S1656
11
D21S11
27,31.2
D22S1045
11,16
D2S1338
24
D2S441
11.3,14
D3S1358
18
D5S818
12,13,14
D7S820
12
D8S1179
10,13
FGA
21,23
Penta D
9,12
Penta E
7,19
TH01
7
TPOX
8
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.

Stronach E.A., Saez-Rodriguez J., Yusa K., Garnett M.J.

Nature 568:511-516(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Molecular portrait of breast-cancer-derived cell lines reveals poor similarity with tumors.

Cifani P., Kirik U., Waldemarson S., James P.

J. Proteome Res. 14:2819-2827(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

Modeling precision treatment of breast cancer.";

Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.

Genome Biol. 14:R110.1-R110.14(2013).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.

Ringner M., Hoglund M., Borg A.

Genes Chromosomes Cancer 46:543-558(2007).

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

Elenius K., Isola J.J.

Mol. Cancer Ther. 3:1585-1592(2004).